Indication

RADICAVA® is indicated to treat:

  • Amyotrophic Lateral Sclerosis

Drug Summary

RADICAVA, Edaravone, is a prescription drug used for the treatment of Amyotrophic Lateral Sclerosis. Administration of RADICAVA is initially 14 days of intravenous infusion followed by a 14 day drug free period with subsequent treatments cycles being 10 days out of 14 of intravenous infusion, followed by 14 day drug free periods.

 

More Information

For more information, click here to visit the manufacturer’s website: https://www.radicava.com/patient/

Ready to Start with Specialty Infusion?

It’s easy to transition your treatment to Specialty Infusion. Here’s how it works:

Ask your doctor to send a prescription, clinical notes, demographics and your insurance card.

One of our Care Coordinators will contact you to confirm receipt of your referral and provide guidance on the next steps.

Your Care Coordinator will contact your insurance company to conduct an investigation of benefits and initiate authorization to ensure coverage of your treatment.

Our team works diligently to expedite the authorization process. Once approval is obtained, your Care Coordinator will contact you to schedule an appointment.